Advertisement
Australia markets close in 1 hour 9 minutes
  • ALL ORDS

    8,105.30
    -100.20 (-1.22%)
     
  • ASX 200

    7,871.30
    -92.40 (-1.16%)
     
  • AUD/USD

    0.6543
    -0.0040 (-0.60%)
     
  • OIL

    76.93
    -0.66 (-0.85%)
     
  • GOLD

    2,375.70
    -40.00 (-1.66%)
     
  • Bitcoin AUD

    98,084.77
    -2,583.46 (-2.57%)
     
  • CMC Crypto 200

    1,308.52
    -57.37 (-4.20%)
     
  • AUD/EUR

    0.6034
    -0.0033 (-0.55%)
     
  • AUD/NZD

    1.1062
    -0.0031 (-0.28%)
     
  • NZX 50

    12,407.65
    -123.35 (-0.98%)
     
  • NASDAQ

    19,032.39
    -721.91 (-3.65%)
     
  • FTSE

    8,153.69
    -13.68 (-0.17%)
     
  • Dow Jones

    39,853.87
    -504.23 (-1.25%)
     
  • DAX

    18,387.46
    -170.24 (-0.92%)
     
  • Hang Seng

    17,064.97
    -246.08 (-1.42%)
     
  • NIKKEI 225

    38,044.91
    -1,109.94 (-2.83%)
     

3 Biotech Stocks Under $15 Worth a Second Look in 2023

3 Biotech Stocks Under $15 Worth a Second Look in 2023

Novavax stands out with its more traditional, protein-based COVID-19 vaccine; MannKind is making a name for itself with inhaled therapies for diabetics and patients with lung disorders; and Anavex has a promising Alzheimer's therapy.